Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
18.03B | 21.58B | 19.24B | 19.68B | 16.94B | 8.09B | Gross Profit |
3.61B | 4.82B | 3.64B | 3.17B | 2.47B | 1.43B | EBIT |
2.38B | 3.51B | 2.59B | 2.23B | 1.64B | 840.48M | EBITDA |
2.57B | 3.82B | 2.82B | 2.46B | 1.85B | 1.04B | Net Income Common Stockholders |
1.64B | 2.39B | 1.80B | 1.61B | 1.16B | 579.87M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
7.70B | 6.90B | 9.71B | 9.58B | 10.64B | 10.46B | Total Assets |
28.37B | 32.62B | 29.95B | 27.91B | 29.32B | 22.14B | Total Debt |
0.00 | 2.00B | 0.00 | 0.00 | 0.00 | 2.96M | Net Debt |
-7.70B | -4.90B | -9.71B | -9.58B | -10.64B | -10.46B | Total Liabilities |
9.60B | 12.99B | 10.24B | 9.33B | 11.91B | 5.39B | Stockholders Equity |
18.76B | 19.63B | 19.71B | 18.58B | 17.41B | 16.75B |
Cash Flow | Free Cash Flow | ||||
0.00 | -2.44B | 1.24B | -507.45M | 628.73M | 4.73B | Operating Cash Flow |
0.00 | -1.53B | 1.52B | -459.20M | 1.37B | 5.16B | Investing Cash Flow |
0.00 | -815.86M | -291.83M | -55.35M | -759.39M | -363.40M | Financing Cash Flow |
0.00 | -366.85M | -1.10B | -541.03M | -439.26M | -525.03M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥19.00B | 7.79 | 5.12% | 16.52% | 39.65% | ||
79 Outperform | ¥20.25B | 11.96 | 3.36% | 15.17% | 36.74% | ||
72 Outperform | ¥20.19B | 7.96 | 5.03% | -4.51% | -4.46% | ||
69 Neutral | ¥17.62B | 29.89 | 0.78% | 6.07% | 69.01% | ||
67 Neutral | ¥22.05B | 24.44 | 6.15% | 3.00% | -62.95% | ||
66 Neutral | $4.46B | 12.11 | 5.38% | 5.02% | 4.17% | -11.82% | |
51 Neutral | ¥16.46B | 143.63 | 4.69% | -3.27% | -104.42% |